A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
מצבים רפואיים
Chronic Lymphocytic Leukemia · Lymphoma, Small Lymphocytic
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Mitchell Cancer Institute, Mobile, Alabama, United States
Contact: Principal Investigator (Anita Mazloom)Arizona Oncology Associates, P.C. - HOPE, Tucson, Arizona, United States
Contact: Principal Investigator (Sudhir Manda)Cancer Specialists, LLC, Jacksonville, Florida, United States
Contact: Principal Investigator (Ayed Ayed)Minnesota Oncology Hematology, P.A., Coon Rapids, Minnesota, United States
Contact: Principal Investigator (Avina Singh)Cayuga Cancer Center, Ithaca, New York, United States
Contact: Principal Investigator (Cynthia Davis)Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York, New York, United States
Contact: Principal Investigator (Prioty Islam)Oncology Hematology Care Inc, Cincinnati, Ohio, United States
Contact: Principal Investigator (Kruti Patel)Texas Oncology - Paris, Fort Worth, Texas, United States
Contact: Principal Investigator (Harris Naina)US Oncology - Texas Oncology, Kyle, Texas, United States
Contact: Principal Investigator (David Friedman)Liverpool Hospital, Liverpool, Australia
Contact: Principal Investigator (Minh Hua)The Alfred Hospital, Melbourne, Australia
Contact: Principal Investigator (Constantine Tam)LKH - Universitätsklinikum der PMU Salzburg, Salzburg, Austria
Contact: Principal Investigator (Alexander Egle)AZ Delta, Roeselare, Belgium
Contact: Principal Investigator (Lien Deleu)Princess Margaret Cancer Centre - University Health Network, Toronto, Canada
Contact: Principal Investigator (Christine Chen)Xuanwu Hospital Capital Medical University, Beijing, China
Contact: Principal Investigator (Wuhan Hui)Hunan Cancer Hospital, Changsha, China
Contact: Principal Investigator (Hui Zhou)Sun Yat-sen University Cancer Center, Guangdong, China
Contact: Principal Investigator (He Huang)Nanfang Hospital of Southern Medical University, Guangzhou, China
Contact: Principal Investigator (RU FENG)Gansu Provincial Cancer Hospital, Lanzhou, China
Contact: Principal Investigator (Jie Cui)The First Affiliated Hospital of Nanchang University, Nanchang, China
Contact: Principal Investigator (Fei Li)Fudan University Shanghai Cancer Center, Shanghai, China
Contact: Principal Investigator (Junning Cao)Taizhou Hospital of Zhejiang Province, Taizhou, China
Contact: Principal Investigator (Qunyi Guo)Hematology Hospital of the Chinese Academy of Medical Sciences, Tianjin, China
Contact: Principal Investigator (Rui Lv)Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
Contact: Principal Investigator (Lihua Qiu)Affiliated Cancer Hospital of Xinjiang Medical University, Ürümqi, China
Contact: Principal Investigator (Shune Yang)The Affiliated Hospital of Xuzhou Medical College, Xuzhou, China
Contact: Principal Investigator (Jiang Cao)Henan Cancer Hospital, Zhengzhou, China
Contact: Principal Investigator (Keshu Zhou)University Hospital Center Zagreb, Zagreb, Croatia
Contact: Principal Investigator (Igor Aurer)Fakultni nemocnice Hradec Kralove, Hradec Králové, Czechia
Contact: Principal Investigator (Martin Simkovic)Centre Henri Becquerel, Rouen, France
Contact: Principal Investigator (Stéphane Leprêtre)Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, Budapest, Hungary
Contact: Principal Investigator (Zoltan Matrai)Debreceni Egyetem, Debrecen, Hungary
Contact: Principal Investigator (Illes Arpad)St. James's Hospital, Dublin, Ireland
Contact: Principal Investigator (Carmel Waldron)Beaumont Hospital, Dublin, Ireland
Contact: Principal Investigator (Philip Murphy)Azienda Ospedaliero - Universitaria Nazionale Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
Contact: Principal Investigator (Gioacchino Catania)Azienda Ospedaliera Universitaria Careggi, Florence, Italy
Contact: Principal Investigator (alessandro sanna)Presidio Ospedaliero Papardo, Messina, Italy
Contact: Principal Investigator (Donato Mannina)Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
Contact: Principal Investigator (Carlo Gambacorti-Passerini)Azienda Ospedaliera di Perugia Ospedale S. Maria della Misericordia, Perugia, Italy
Contact: Principal Investigator (PAOLO SPORTOLETTI)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
Contact: Principal Investigator (LUCA LAURENTI)Tel Aviv Sourasky Medical Center, Tel Aviv, Italy
Contact: Principal Investigator (Yair Herishanu)Azienda Ospedaliera S. Maria Di Terni, Terni, Italy
Contact: Principal Investigator (Arcangelo Liso)Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Roma, Verona, Italy
Contact: Principal Investigator (Isacco Ferrarini)Tokai University Hospital, Isehara, Japan
Contact: Principal Investigator (Yoshiaki Ogawa)Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onkologiczny im.ks.B.Markiewicza, Brzozów, Poland
Contact: Principal Investigator (Jacek Krzanowski)Szpital Uniwersytecki Nr 2 im. dr J. Biziela w Bydgoszczy, Bydgoszcz, Poland
Contact: Principal Investigator (Marta Sobas)Pratia Onkologia Katowice, Katowice, Poland
Contact: Principal Investigator (Sebastian Grosicki)Instytut Hermatologii I Transfuzjologii, Warsaw, Poland
Contact: Principal Investigator (Ewa Lech-Maranda)Hospital Universitario Marques De Valdecilla, Santander, Spain
Contact: Principal Investigator (LUCRECIA YANEZ SAN SEGUNDO)Hospital Universitario Virgen Del Rocio, Seville, Spain
Contact: Principal Investigator (Fatima de la Cruz Vicente)Castle Hill Hospital, Hull, United Kingdom
Contact: Principal Investigator (David Allsup)St James's University Hospital, Leeds, United Kingdom
Contact: Principal Investigator (Talha Munir)GenesisCare, Newmarket, United Kingdom
Contact: Principal Investigator (George Follows)
מובילי המחקר
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company